Skip to content

Quality of Life in Patients With Bladder Cancer

A Prospective Study of Quality of Life in Patients With Bladder Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00745355
Enrollment
550
Registered
2008-09-03
Start date
2008-08-01
Completion date
2026-08-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

Quality of Life, Questionnaires, 08-076

Brief summary

The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.

Interventions

BEHAVIORALQuality Of Life questionnaires

All patients who agree to participate will be interviewed using a baseline idiographic quality of life assessment prior to surgery and at approximately 6, 12, 18 and 24 months postoperatively. All patients will also be asked to respond to a questionnaire including all standard measures (closed-ended, multiple choice items) before surgery and at approximately 3, 6, 12, 18 and 24 months post-surgery.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER
Albert Einstein College of Medicine
CollaboratorOTHER
Northwell Health
CollaboratorOTHER
Lenox Hill Hospital
CollaboratorOTHER
DeltaQuest Foundation, Inc.
CollaboratorUNKNOWN
Lahey Hospital & Medical Center
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* All patients (male and female) who are diagnosed with bladder cancer * Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy. * Participants must be able to speak English. * Participants must be able to provide informed consent. * Participants must be 18 years of age or older to enroll. * Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy. * Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).

Exclusion criteria

* Subjects may be excluded from the study based on the following criteria: * Follow-up care not obtained at MSKCC. * Metastatic disease at diagnosis.

Design outcomes

Primary

MeasureTime frame
Prospectively characterize the impact of radical cystectomy and different urinary diversions on quality of life of bladder cancer patients.conclusion of study

Secondary

MeasureTime frame
Compare various standard and idiographic measures of QOL, to determine their relative contributions in accounting for variance in key outcome criteria and prediction of patient QOL at subsequent assessment points.conclusion of study
Examine how patients react to more in-depth probing of the interview associated with idiographic assessment.conclusion of study
Develop a predictive model of QOL after radical cystectomy & urinary diversion using the data from idiographic and standard QOL measures. This model can ultimately be used in office based practice to guide treatment planning with each patient.conclusion of study

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBernard Bochner, MD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026